Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim resultsSham Mailankody, Shaji Kumar, Surbhi Sidana et al.|Nature Medicine|2023Cited by 239
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT StudyRoy F. Chemaly, Ella Ariza‐Heredia, Lynn El Haddad et al.|Clinical Infectious Diseases|2020Cited by 109